PPB - Services

Complaints, Feedback and Enquiry

Medicine Quality Alert: Class II Recall of A.P.C Tablets (Paracetamol B.P, Aspirin B.P, and Caffeine Anhydrous B.P)

Biodeal Laboratories Ltd has initiated a voluntary recall of A.P.C Tablets (Paracetamol B.P, Aspirin B.P, and Caffeine Anhydrous B.P ) BN 1223038

From: Pharmacy and Poisons Board

Date of Recall Initiation: 7th February 2025

Recall Reference Number: REC/2025/004

Recall Classification: Class II

Recall Level: Retail/Facility level

Manufacturer: Biodeal Laboratories Ltd

Product name: A.P.C

Active Pharmaceutical Ingredients: Aspirin B.P., Paracetamol, and Caffeine Anhydrous B.P

Affected counties: All

Affected Batch

Batch Number

Date of Manufacture

Date of expiry

Pack Size

1223038

12/2023

11/2026

Pack of 100’s

Brief description of the problem

The product is being recalled due to out-of-specification results on uniformity of weight

Action for healthcare professionals

Stop supplying the above batches immediately. Quarantine all remaining stock and await contact from Biodeal Laboratories Ltd, Kenya, who will contact healthcare professionals directly to arrange the return.

Action for patients and carers

No further action is required by patients as this is a Retail/hospital Pharmacy and Wholesaler/Distributor level recall.

Further Information

For inquiries about consignments of the impacted batches, please contact Biodeal Laboratories Ltd, Kenya, at: regulatoryaffairs@biodealkenya.com,    chriskibathi@biodealkenya.com, freshia@biodealkenya.com or via telephone: +254 722 214178

Promptly report any cases of adverse events and suspected substandard and falsified products to the nearest healthcare facility or through the following channels:

For any further information please contact the Pharmacy and Poisons Board by email: pms@ppb.go.ke

Download document

Medicine Quality Alert: Class II Recall of A.P.C Tablets (Paracetamol B.P, Aspirin B.P, and Caffeine Anhydrous B.P)